Director/PDMR Shareholding and issue of equity

RNS Number : 1792T

Judges Scientific PLC

10 December 2012

 

Judges Scientific plc (the "Company")

10 December 2012

Exercise of Options and Director/PDMR Shareholding

Exercise of Options:  The Company has today issued 8,000 new Ordinary Shares of 5p each in the Company ("Ordinary Shares") pursuant to exercises of options by two option holders under the Company's Approved Share Option Scheme. Application has been made for the new Ordinary Shares to be admitted to AIM and dealings are expected to commence on 14 December 2012.

Of the 8,000 new Ordinary Shares, 5,000 shares were allotted to David Barnbrook, a Director and the Chief Operating Officer of the Company.  In accordance with his instructions, the new Ordinary Shares will be registered in the name of his wife, Lynne Margaret Barnbrook.  Mrs Barnbrook has today sold 3,000 Ordinary Shares of her pre-existing holding at 975p per share.

Following the exercise of these options and the above sale of shares, the enlarged issued share capital is 5,309,499 Ordinary Shares and David Barnbrook's interest is 22,248 Ordinary Shares representing 0.42 per cent. of this enlarged issued share capital.  In addition, he holds remaining options over 50,000 Ordinary Shares under the Company's Share Option Plans.

Share Incentive Plan:  The Company was notified on 7 December 2012 by the Trustees of the Share Incentive Plan of the purchase of 104 Ordinary Shares on behalf of the Company's Chief Executive Officer, David Cicurel, to which the Company added a further 62 Ordinary Shares under the "matching" provisions of the Plan rules.  His resulting interest in the Company is 916,236 Ordinary Shares representing 17.26 per cent. of the issued Ordinary Share capital as enlarged by the above issue of new shares.

In addition, the Trustees purchased 13 Ordinary Shares on behalf of the Company's Finance Director, Ralph Cohen.  His resulting interest in the Company is 50,755 Ordinary Shares and represents 0.96 per cent. of the issued Ordinary Share capital as enlarged by the above issue of new shares.  In addition, he holds options over 43,100 Ordinary Shares under the Company's Share Option Plans.

The purchases by the Trustees were made at 955p per Ordinary Share.  Purchases of a further 512 Ordinary Shares were made on the same date and at the same price for 48 other members of staff under the Plan.

Enquiries:

Judges Scientific plc

David Cicurel, CEO

01342 323 600

Shore Capital

Pascal Keane

020 7408 4090

Cardew Group

Melvyn Marckus

07775 896491

 

END

 

 

RDSBUBDDRDBBGDG